BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 28322181)

  • 1. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
    Sinha D; Saha P; Samanta A; Bishayee A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.
    Celià-Terrassa T; Jolly MK
    Cold Spring Harb Perspect Med; 2020 Jul; 10(7):. PubMed ID: 31570380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
    Bocci F; Tripathi SC; Vilchez Mercedes SA; George JT; Casabar JP; Wong PK; Hanash SM; Levine H; Onuchic JN; Jolly MK
    Integr Biol (Camb); 2019 Jun; 11(6):251-263. PubMed ID: 31329868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
    Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
    Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
    Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
    Pietilä M; Ivaska J; Mani SA
    Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Bocci F; Gearhart-Serna L; Boareto M; Ribeiro M; Ben-Jacob E; Devi GR; Levine H; Onuchic JN; Jolly MK
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):148-157. PubMed ID: 30587589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
    Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
    Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells.
    Chen L; Boleslaw Olszewski M; Kruithof-de Julio M; Snaar-Jagalska BE
    Cells; 2020 Mar; 9(4):. PubMed ID: 32225005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Cooperativity in miR200-Zeb Feedback Network can Control Epithelial-Mesenchymal Transition.
    Rashid M; Devi BM; Banerjee M
    Bull Math Biol; 2024 Mar; 86(5):48. PubMed ID: 38555331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.